http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2443159-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87af6348dbe25094aef726328f530ede
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
filingDate 2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46c382481d8fc002aaf76bc66e03116e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a78b8fddb22c8dbac4f793ec8810635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_143c7744e84741ded5c7a76f65a3b836
publicationDate 2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2443159-T3
titleOfInvention Topical formulation for diabetic foot ulcers
abstract A topical gel formulation for the treatment of chronic wounds comprising: a. from about 10% to about 20% methyl-3- [4- (2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (Esmolol hydrochloride); b. from about 25% to about 35% poloxamer 338; C. from about 0.2% to about 0.3% 50% benzalkonium chloride; d. from about 0.2% to about 0.3% sodium acetate trihydrate; and. from about 0.03% to about 0.07% glacial acetic acid; F. from about 0.02% to about 0.08% concentrated hydrochloric acid; g. from about 40% to about 60% purified water; and where the formulation has a pH between 4.0 to 6.0 and has heat-reversible property and is packed in a suitable container.
priorityDate 2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451197127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449235055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46878362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457834382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447748688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449015241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407866699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18360910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413339604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 42.